Full Text
Comparing Cost-Effectiveness Of Emerging Drugs In Advanced Cancer Without Hazard Ratios For Progression

Abstract

Authors

W Wiecek H Karcher

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×